Here are four findings from the survey, comprising results from 265 finance executives.
1. Thirty-six percent of respondents said the healthcare and life sciences market is a “moderate bubble,” while 22 percent said the market is a “bubble likely to burst.”
2. Respondents said the biggest drivers of merger and acquisition activity in the healthcare and life sciences sector are accretive acquisition strategies (52 percent), cost consolidation (46 percent) and changing payment models (39 percent).
3. Fifty-two percent of respondents predicted the health IT and data subsector will have “a lot” of investment activity next year.
4. Respondents said the most overvalued sectors include biotech (71 percent), specialty physician practice management (67 percent), behavioral health (63 percent) and health IT (58 percent).
More articles on healthcare finance:
Cash-strapped Nashville hospital struggles with basic bookkeeping, city seeks to halt inpatient services: 7 things to know
Sharp HealthCare’s operating income tumbles 49%
High-deductible health plans don’t significantly curb spending on 26 low-value services
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
